期刊文献+

新型白血病骨髓基质细胞黏附介导耐药模型构建的探索性研究 被引量:4

Exploratory study of novel leukemia bone marrow stromal cell adhesion mediated drug resistance CHEN Xing-hua GAO Lei ZHANG Xi WANG Ji-gang ZHANG Cheng PENG Xian-gui LI
原文传递
导出
摘要 目的以急性淋巴细胞白血病(ALL)患者骨髓基质细胞(BMSC)构建白血病细胞黏附介导耐药(CAM-DR)模型,从一新的角度探讨 CAM-DR 在白血病细胞耐药中的作用。方法采用人淋巴细胞白血病 Jurkat 细胞株与经^(60)Co 射线照射后的 ALL 骨髓基质细胞贴壁层共培养构建 CAM-DR模型,应用扫描电镜从形态及结构对该模型进行鉴定;四甲基偶氮唑盐比色法(MTF 法)和流式细胞仪分别测定柔红霉素(DNR)对 Jurkat 细胞的细胞毒作用、DNR 在 Jurkat 细胞中的储积浓度及分布。结果扫描电镜结果显示 CAM-DR 模型中 Jurkat 细胞通过伪足黏附于骨髓基质细胞层,或移行到骨髓基质细胞层下,并可见 Jurkat 细胞呈巢状龛于骨髓基质细胞"网眼"中。流式细胞结果显示该模型并末影响 DNR 在 Jurkat 细胞中的蓄积及药物的分布,但显著抑制了 Jurkat 细胞对 DNR 的反应性。结论成功构建了以白血病 BMSC 为基础的 CAM-DR 模型,为进一步研究白血病细胞耐药机制奠定了理论和实验基础。 Objective To construct cell adhesion mediated drug resistance (CAM-DR) model based on Acute lymphocyte leukemia bone marrow stromal cells(BMSC) for further studying drug resistance of leukemia. Methods Firstly, we adhesively cultured Jurkat cell strain of human leukaemia lymphocyte with the matrix cell radiated by ^60Co to construct the model of CAM-DR, then elatuated the model in morph and construction by scanning electron microscope. The ICS0 of DNR on Jurkat cell was examed by MTT and the concentration and distribution of DNR in the cell was detected by flow cytometry. Results When the Jurkat cells were cultured with BMSC for 24 h, we found that Jurkat cells had adhsioned the bone marrow stromal cell layer by parapodium and some of them had niched the mesh constited by the confluence of BMSC. At the point of 48 h, some Jurkat cells had migrated to underlayer of BMSC, and Jurkat cells were niched the mesh of BMSC like nidi. The accumulation and distribution of DNR in the Jurkat cells were not affected in the model, but the reaction of Jurkat cells to DNR were significantly inhibited. Conclusion The model of CAM-DR based on Acute lymphocyte leukemia bone marrow stromal cells was successfully built.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第20期1380-1383,共4页 National Medical Journal of China
基金 国家自然科学基金(39770335)
关键词 白血病 骨髓基质细胞 多药耐药 细胞黏附 细胞黏附介导耐药 Leukemia Bone Marrow Stromal Cells Multi-drug resistance Cell adhesion Cell adhesion mediated drug resistance
  • 相关文献

参考文献15

  • 1Hazlehurst LA, Dalton WS. Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev, 2001 , 20: 43-50.
  • 2Weekes CD, Kuszynski CA, Sharp JG. VLA-4 mediated adhesion to bone marrow stromal cells confers chemoresistance to adherent lymphoma cells, Leuk Lymphoma,2001,40: 631-645.
  • 3Nefedova Y, Landowski TH,Dalton WS. Bone marrow stromalderived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia, 2003, 17 : 1175-1182.
  • 4Hazlehurst LA, Landowski TH, Daltton WS. Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death. Oncegene, 2003,22: 7396- 7402.
  • 5Wang L, Fortney JE, Gibson LF. Stromal cell protection of B- lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt Leuk Res, 2004, 28: 733-742.
  • 6Paraguassu-Braga FH, Borojevic R, Bouzas LF, et al. Bone marrow stroma inhibits proliferation and apoptosis in leukemic cells through gap junction-mediated cell communication. Cell Death Differ, 2003, 10: 1101-1108.
  • 7Damiano JS, Hazlehurst LA, Dalton WS. Cell adhesion-mediated drug resistance ( CAM-DR ) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation. Leukemia, 2001, 15 : 1232-1237.
  • 8Kruh GD. Introduction to resistance to anticancer agent Oncegene, 2003, 22 : 7262-7264.
  • 9秦慧,刘霆,杨金亮,黄欣,柳斌,宋鑫,赵霞,魏于全.蛋白质组学方法筛选维甲酸耐药相关蛋白[J].中华医学杂志,2007,87(8):520-525. 被引量:8
  • 10Hazlehurst LA, Dalton WS. Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies. Cancer Metastasis Rev, 2001, 20: 43-50.

二级参考文献17

  • 1Kirchhoff SR, Gupta S , Knowlton AA. Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation, 2002,105 : 2899-2904.
  • 2Kinumi T, Kimata J, Taira T, et al. Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells.Biochem Biophys Res Commun, 2004, 317: 722-728.
  • 3Groenendyk J, Lynch J , Michalak M. calreticulin, Ca^2+ and calcineurin signaling from the Endoplasmic Reticulum. Mol Cells,2004, 17: 383-389.
  • 4Burns K, Duggan B, Atkinson E, et al. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor.Nature, 1994, 367 : 476-480.
  • 5Bandopadhyay R, Kingsbury AE, Cookson MR, et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain, 2004, 127 : 420-430.
  • 6Arnaudeau S, Frieden M, Nakamura K, et al. Calreticulin Differentially Modulates Calcium Uptake and Release in the Endoplasmic Reticulum and Mitochondria. J Biol Chem, 2002,277 : 46696-46705.
  • 7Desai D, Michalak M, Singh NK, et al. Inhibition of Retinoic Acid Receptor Function and Retinoic Acid-regulated Gene Expression in Mouse Melanoma Cells by Calreticulin. J Biol Chem, 1996, 271 : 15153-15159.
  • 8Lau TY, He QY, Chiu JF. Proteomic Technology and Its Biomedical Applications. Acta Biochimica et Biophysica Sinica,2003, 35: 965-975.
  • 9Nervi C, Ferrara FF, Fanelli M, et al. Caspase mediate Retinoid Acid-Induced Degredation of the acute promyelocytic Leukemia PML/RAR fusion Protein. Blood, 1998, 92: 2244-2251.
  • 10Gallagher RE. Retinoic acid resistance in acute promyelocytic leukemia. Leukemia, 2002, 16: 1940-1958.

共引文献17

同被引文献44

  • 1张剑白,孙媛,董娟,刘丽晓,宁芳.儿童急性白血病初治患者LRP和MRP的表达及其临床意义[J].癌症,2005,24(8):1015-1017. 被引量:2
  • 2秦慧,刘霆,杨金亮,黄欣,柳斌,宋鑫,赵霞,魏于全.蛋白质组学方法筛选维甲酸耐药相关蛋白[J].中华医学杂志,2007,87(8):520-525. 被引量:8
  • 3王丹,克晓燕,王晶,徐芳,胡永芳.MDR1基因多态性与急性髓细胞白血病化学疗法结果的相关性研究[J].中华医学杂志,2007,87(20):1384-1388. 被引量:3
  • 4胡永芳,周宏灏.应重视白血病多药耐药的遗传机制研究[J].中华医学杂志,2007,87(24):1657-1659. 被引量:1
  • 5Lin L,Tian H,Yue W,et al. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vitro. J Cell Physiol, 2011,226(7) :1860-1867.
  • 6Xu WT, Bian ZY, Fan QM, et al. Human mesenchymal stem ceils (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. Cancer Lett,2009,281 ( 1 ) :32-41.
  • 7Nauta A J, Fibbe WE. Immunomodulatory properties of mesenehymal stromal cells. Blood, 2007,110 ( I 0 ) : 3499 -3506.
  • 8Ning H, Yang F, Jiang M, et al. The correlation between eotrans- plantation of mesenehymal stem cells and higher recurrence rate in hematologic malignancy patients:outcome of a pilot clinical study. Leukemia,2008,22 ( 3 ) :593-599.
  • 9Lutz P, Mueller,Jana L, et al. Presenee of mesenehymal stem cells in human bone marrow after exposure to chemotherapy:evldence of resistance to apoptosis induction. Stem Cells, 2006,24 ( 12 ) :2753- 2765.
  • 10Li H, Ting L,Jing T, et al. Long-term culture of leukemie hone mar- row primary cells in biomimetie osteoblast niche. Int J Hematol, 2009,90(3) :281-291.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部